Early detection of Alzheimers disease with a total score of the German CERAD

Journal of the International Neuropsychological Society

Volumn 16, Issue 5, 2010, Pages 910-920

  Ehrensperger, Michael M ^a   Berres, Manfred ^b   Taylor, Kirsten I ^a,c   Monsch, Andreas U ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES KOBLENZ   (Germany)

^c UK   (United Kingdom)

Author keywords

Change score; Cognition; Dementia; Longitudinal study; Neuropsychological test; Neuropsychology

Indexed keywords

AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; REPRODUCIBILITY; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AREA UNDER CURVE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS;

EID: 79451473171     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617710000822     Document Type: Article

References (38)

1. Aebi, C. (2002). Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi-Center Studie [Validation of the CERAD neuropsychological assessment battery: A multi centre study]. Unpublished doctoral dissertation, University of Basel, Basel, Switzerland.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental Disorders (4th ed.). Washington, DC : American Psychiatric Association Press.
3. Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC : War Department, Adjutant General's Office.
4. Berres, M., Zehnder, A., Bläsi, S., & Monsch, A.U. (2007). Evaluation of diagnostic scores with adjustment for covariates. Statistics in Medicine, 27, 1777-1790.
5. Brodaty, H., Corey-Bloom, J., Potocnik, F.C., Truyen, L., Gold, M., & Damaraju, C.R. (2005). Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 20, 120-132.
6. Chandler, M.J., Lacritz, L.H., Hynan, L.S., Barnard, H.D., Allen, G., Deschner, M., et al. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65, 102-106.
7. Ermini-Fünfschilling, D., & Meier, D. (1995). Gedächtnistraining: Wichtiger Bestandteil der Milieutherapie bei seniler Demenz [Memory training: An important constituent of milieu therapy in senile dementia]. Zeitschrift für Gerontologie und Geriatrie, 28, 190-194.
8. Fillenbaum, G.G., Unverzagt, F.W., Ganguli, M., Welsh-Bohmer, K.A., & Heyman, A. (2002). The CERAD Neuropsychological Battery: Performance of representative community and tertiary care samples of African-American and European-American elderly. In F.R. Ferraro (Ed.), Minority and cross-cultural aspects of neuropsychological assessment. Lisse, Netherlands : Swets & Zeitlinger.
9. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). "Mini- Mental State" - A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
10. Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A., et al. (2008). PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging, 29, 1456-1465.
11. Grimmer, T., Perneczky, R., & Kurz, A. (2008). Aktueller Stand der Immuntherapie bei Alzheimer-Krankheit [Current immune therapy for Alzheimer's disease]. Nervenarzt, 79, 832-835.
12. Hanley, J.A., & McNeil, B.J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148, 839-843.
13. Härting, C., Markowitsch, H.J., Neufeld, H., Calabrese, P., Deisinger, K., & Kessler, J. (Eds.). (2000). Wechsler Gedächtnistest - revidierte Fassung [Wechsler Memory Scale - revised edition]. Bern, Switzerland : Huber.
14. Kühner, C. (1997). Fragebogen zur Depressionsdiagnostik nach DSM-IV (FDD DSM-IV) [German Version of the Inventory to Diagnose Depression according to DSM-IV]. Göttingen, Germany: Hogrefe.
15. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939-944.
16. Monsch, A.U., Foldi, N.S., Ermini-Fünfschilling, D.E., Berres, M., Taylor, K.I., Seifritz, E., et al. (1995). Improving the diagnostic accuracy of the Mini-Mental State Examination. Acta Neurologica Scandinavica, 92, 145-150.
17. Monsch, A.U., Thalmann, B., Schneitter, M., Bernasconi, F., Aebi, C., Camachova Davet, Z., et al. (2000). The Basel Study on the Elderly's search for preclinical cognitive markers of Alzheimers's disease. Neurobiology of Aging, 21, 31.
18. Morris, J.C., Edland, S., Clark, C., Galasko, D., Koss, E., Mohs, R., et al. (1993). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Ratings of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457-2465.
19. Morris, J.C., Heyman, A., Mohs, R.C., Hughes, J.P., van Belle, G., Fillenbaum, G., et al. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159-1165.
20. Morris, J.C., Mohs, R.C., Rogers, H., Fillenbaum, G., & Heyman, A. (1988). Consortium to Establish a Registry for Alzheimer's Disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacology Bulletin, 24, 641-652.
21. Nelson, H.E. (1976). A modified card sorting test sensitive to frontal lobe defects. Cortex, 12, 313-324.
22. Panisset, M., Roudier, M., Saxton, J., & Boller, F. (1994). Severe impairment battery: A neuropsychological test for severely demented patients. Archives of Neurology, 51, 41-45.
23. Pike, K.E., Savage, G., Villemagne, V.L., Ng, S., Moss, S.A., Maruff, P., et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain, 130, 2837-2844.
24. Regard, M., Strauss, E., & Knapp, P. (1982). Children's production on verbal and non-verbal fluency tasks. Perceptual and Motor Skills, 55, 839-844.
25. Rogers, S.L., Farlow, M.R., Doody, R.S., Mohs, R., & Friedhoff, L.T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology, 50, 136-145.
26. Rosen, W.G., Mohs, R.C., & Davis, K.L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356-1364.
27. Rosetti, H.C., Cullum, C.M., Hynan, L.S., & Lacritz, L.H. (2010). The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Disease and Associated Disorders, 24, 138-142.
28. Seltzer, B., Zolnouni, P., Nunez, M., Goldman, R., Kumar, D., Ieni, J., et al. (2004). Efficacy of donepezil in early-stage Alzheimer's disease: A randomized placebo controlled trial. Archives of Neurology, 61, 1852-1856.
29. Sheikh, J.I., & Yasavage, J.A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In T.L. Brink (Ed.), Clinical gerontology: A guide to assessment and intervention (pp. 165-174). New York : The Haworth Press.
30. Tariot, P.N., Solomon, P.R., Morris, J.C., Kershaw, P., Lilienfeld, S., & Ding, C. (2000). A 5-month, randomized, placebocontrolled trial of galantamine in AD. Neurology, 54, 2269-2276.
31. Thalmann, B., Monsch, A.U., Schneitter, M., Bernasconi, F., Aebi, C., Camachova Davet, Z., et al. (2000). The CERAD neuropsychological assessment battery (CERAD-NAB) - A minimal dataset as a common tool for German-speaking Europe. Neurobiology of Aging, 21, 30.
32. Thurstone, L.L. (1938). Primary mental abilities. Chicago : University of Chicago Press.
33. Welsh, K.A., Butters, N., Hughes, J., Mohs, R., & Heyman, A. (1991). Detection of abnormal memory in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology, 48, 278-281.
34. Welsh, K.A., Butters, N., Hughes, J., Mohs, R., & Heyman, A. (1992). Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's disease (CERAD). A rchives of Neurology, 49, 448-452.
35. Welsh, K.A., Butters, N., Mohs, R.C., Beekly, D., Edland, S., Fillenbaum, G., et al. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology, 44, 609-614.
36. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., et al. (2004). Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240-246.
37. Wouters, H., van Gool, W.A., Schmand, B., & Lindeboom, R. (2008). Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Disease and Associated Disorders, 22, 236-244.
38. Zehnder, A.E., Bläsi, S., Berres, M., Spiegel, R., & Monsch, A.U. (2007). Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? American Journal of Alzheimer's Disease and Other Dementias, 22, 416-426.